DE69032681D1 - Cephalosporine und ihre Homologen, Verfahren zu ihrer Herstellung und pharmazeutische Präparate - Google Patents

Cephalosporine und ihre Homologen, Verfahren zu ihrer Herstellung und pharmazeutische Präparate

Info

Publication number
DE69032681D1
DE69032681D1 DE69032681T DE69032681T DE69032681D1 DE 69032681 D1 DE69032681 D1 DE 69032681D1 DE 69032681 T DE69032681 T DE 69032681T DE 69032681 T DE69032681 T DE 69032681T DE 69032681 D1 DE69032681 D1 DE 69032681D1
Authority
DE
Germany
Prior art keywords
processes
preparation
optionally
cephalosporins
homologues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69032681T
Other languages
English (en)
Other versions
DE69032681T2 (de
Inventor
John Hargreaves Bateson
George Burton
Stephen Christopher Marti Fell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898907171A external-priority patent/GB8907171D0/en
Priority claimed from GB898920791A external-priority patent/GB8920791D0/en
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE69032681D1 publication Critical patent/DE69032681D1/de
Application granted granted Critical
Publication of DE69032681T2 publication Critical patent/DE69032681T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69032681T 1989-03-30 1990-03-26 Cephalosporine und ihre Homologen, Verfahren zu ihrer Herstellung und pharmazeutische Präparate Expired - Fee Related DE69032681T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898907171A GB8907171D0 (en) 1989-03-30 1989-03-30 Novel compounds
GB898920791A GB8920791D0 (en) 1989-09-14 1989-09-14 Novel compounds

Publications (2)

Publication Number Publication Date
DE69032681D1 true DE69032681D1 (de) 1998-11-05
DE69032681T2 DE69032681T2 (de) 1999-02-25

Family

ID=26295148

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69032681T Expired - Fee Related DE69032681T2 (de) 1989-03-30 1990-03-26 Cephalosporine und ihre Homologen, Verfahren zu ihrer Herstellung und pharmazeutische Präparate

Country Status (12)

Country Link
US (1) US5246926A (de)
EP (1) EP0395219B1 (de)
JP (1) JP2979235B2 (de)
KR (1) KR900014403A (de)
AT (1) ATE171705T1 (de)
AU (1) AU625844B2 (de)
CA (1) CA2013391A1 (de)
DE (1) DE69032681T2 (de)
DK (1) DK0395219T3 (de)
ES (1) ES2121745T3 (de)
PT (1) PT93602A (de)
ZA (1) ZA902378B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0432042B1 (de) * 1989-12-07 1996-08-28 Meiji Seika Kaisha Ltd. Cephalosporinderivate, ihre Herstellung und Anwendungen
US6020329A (en) * 1990-07-24 2000-02-01 Pzifer Inc. Cephaloporins and homologues, preparations and pharmaceutical compositions
MY106399A (en) * 1990-07-24 1995-05-30 Pfizer Cephalosporins and homologeus, preparation and pharmaceutical composition
US6001997A (en) * 1990-07-24 1999-12-14 Bateson; John Hargreaves Cephalosporins and homologues, preparations and pharmaceutical compositions
GB9019743D0 (en) * 1990-09-10 1990-10-24 Beecham Group Plc Novel compounds
DE4037841A1 (de) * 1990-11-28 1992-06-04 Bayer Ag Neue 3-substituierte cephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
IT1251643B (it) * 1991-10-29 1995-05-17 Mini Ricerca Scient Tecnolog Derivati maleimmidici contenenti residui acrilici
GB9125645D0 (en) * 1991-12-03 1992-01-29 Smithkline Beecham Plc Novel compounds
US5302711A (en) * 1992-02-18 1994-04-12 Eli Lilly And Company Ester cleavage process for use with β-lactams
GB9212609D0 (en) * 1992-06-13 1992-07-29 Smithkline Beecham Plc Novel compounds
GB9213567D0 (en) * 1992-06-26 1992-08-12 Smithkline Beecham Plc Novel compounds
US5604222A (en) 1993-12-27 1997-02-18 Lupin Laboratories, Ltd. Method for the preparation of 2-chloro sulfinyl azetidinones
US5578721A (en) 1994-07-11 1996-11-26 Lupin Laboratories Limited Process for preparation of 3-exomethylene cepham sulfoxide esters
GB9424847D0 (en) * 1994-12-09 1995-02-08 Smithkline Beecham Plc Novel process
IT1277048B1 (it) * 1995-12-06 1997-11-04 3 Exo S R L Procedimento per la preparazione di cefalosporine attraverso ciclizzazione riduttiva dicarbonilica per trattamento con
WO2003053522A1 (en) * 2001-12-21 2003-07-03 Pfizer Products Inc. Methods of treating bacterial infections in dogs and cats
US20040002600A1 (en) * 2002-06-20 2004-01-01 Orchid Chemicals And Pharmaceuticals Limited Process for the conversion of penam ring system to cepham ring system
KR101599560B1 (ko) * 2007-09-21 2016-03-03 아스트라제네카 아베 비경구 투여에 적합한 세펨 유도체를 함유하는 가용성 제형

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868173A (en) * 1984-11-20 1989-09-19 Ici Pharma Cephalosporin derivatives
GB8821797D0 (en) * 1988-09-16 1988-10-19 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
CA2013391A1 (en) 1990-09-30
EP0395219A3 (de) 1992-04-01
AU5232190A (en) 1990-10-04
US5246926A (en) 1993-09-21
ZA902378B (en) 1991-06-26
JPH02286680A (ja) 1990-11-26
DK0395219T3 (da) 1999-02-15
JP2979235B2 (ja) 1999-11-15
EP0395219A2 (de) 1990-10-31
ES2121745T3 (es) 1998-12-16
ATE171705T1 (de) 1998-10-15
DE69032681T2 (de) 1999-02-25
PT93602A (pt) 1990-11-20
KR900014403A (ko) 1990-10-23
AU625844B2 (en) 1992-07-16
EP0395219B1 (de) 1998-09-30

Similar Documents

Publication Publication Date Title
DE69032681T2 (de) Cephalosporine und ihre Homologen, Verfahren zu ihrer Herstellung und pharmazeutische Präparate
HU906402D0 (en) Process for producing tricyclic carbapeneme derivatives an pharmaceutical preparatives containing these compounds as active substance
DE3750443T2 (de) Cephalosporinverbindungen, Verfahren zu ihrer Herstellung und antibakterielle Mittel.
ATE37882T1 (de) Cephalosporinverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ATE220402T1 (de) Basisch substituierte vinylpyrrolidin- cephalosporine
DE2963720D1 (en) Cephalosporin derivatives, their preparation and the corresponding pharmaceutical compositions
EP0359536A3 (de) Cephalosporinderivate, Verfahren zu ihrer Herstellung und pharmazeutische Präparate
ATE113953T1 (de) Cephalosporine, verfahren zu ihrer herstellung und pharmazeutische präparate.
ATE87313T1 (de) Cephemverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ATE130299T1 (de) Cephalosporinverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische präparate.
ES8800236A1 (es) Un procedimiento para obtener acido-7-amino-3-propenilcefalosporanico y sus esteres.
AU556922B2 (en) Pyridobenzodiazepinone derivatives
IL113744A0 (en) 3-Cephem derivatives and their preparation
DE69217613D1 (de) Stickstoff enthaltende bizyklische Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
ES442217A1 (es) Procedimiento para la obtencion de derivados cefem.
ATE32724T1 (de) Cephalosporinverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
EP0354757A3 (de) Cephalosporine und homologe Verbindungen, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
ATE114313T1 (de) Cephalosporine, verfahren zu ihrer herstellung, zwischenverbindungen und pharmazeutische präparate.
PT83712A (de) Cephalosporinderivate und verfahren zu ihrer herstellung
DE3772936D1 (de) Cephalosporinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ATE143963T1 (de) Cephalosporinderivate und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee